ハラール医薬品の世界市場 - 市場規模、シェア、動向、産業分析：医薬品別、剤形別、治療領域別、認証タイプ別、エンドユーザー別、地域別 - 市場予測（2025年～2034年）

世界のハラール医薬品の市場規模は、2034年までに2,053億米ドルに達する見込みです。

ハラール医薬品はイスラム法に準拠し、ハラーム（禁止）成分を含まない医薬品です。従来の医薬品生産とハラール認証プロセスには類似点もありますが、重要な相違点も存在します。ハラール医薬品の成分は、植物、鉱物、水、イスラム法に従って解体された動物に由来します。海洋生物はハラールとみなされ、合成物質は不純物（ナジス）がなく、人間の消費に安全である限り許可されます。

税金、補助金、規制といった政府の政策は、市場の成長に大きな影響を与えます。イスラム教徒が多数を占める多くの国では、医薬品にハラール認証を義務付ける規制が、適合製品に対する市場の需要を後押ししています。また、ハラール医薬品の研究・生産に対する補助金は、技術革新と投資を促進します。ハラール標準を推進する規制枠組みは、ハラール医薬品市場の拡大にさらに有利な環境を作り出しています。

オーガニックで環境にやさしい製品に対する需要の高まりは、今後数年間の市場成長を促進すると予測される大きな市場動向の1つです。イスラム諸国における経済環境の向上は、予測期間に複数のハラール医薬品市場の機会をもたらすと予測されます。

ハラール医薬品市場の主なハイライト

医薬品別では、慢性疾患の流行とハラール認証医薬品のニーズの高まりにより、処方薬セグメントが2024年に最大の市場シェアを占めました。

剤形別では、錠剤・カプセルが2024年に50%の収益シェアで市場をリードしました。これは主に、利便性、患者コンプライアンス、錠剤・カプセル投与の利用しやすさに起因しています。

北米はイスラム教徒の人口が増加しており、成分や調達に関する消費者の意識が高まっているため、2024年の世界のハラール医薬品市場の大部分を占めています。

アジア太平洋のハラール医薬品市場は、同地域のムスリム人口の増加に牽引され、予測期間にもっとも急速に成長する見込みです。

Rosemont Pharmaceuticals、EMBIL Pharmaceutical Co.、Noor Vitamins、Bosch Pharmaceuticals、Chemical Company of Malaysia Berhad、Pharmaniaga Bhd、Nutramedica Incorporated、Simpor Pharma Sdn Bhdは市場の主要企業の一部です。

当レポートでは、世界のハラール医薬品市場について調査し、現在の市場力学の詳細な考察や、将来の市場成長に関する分析を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のハラール医薬品市場の考察

• 用途スナップショット
• ハラール医薬品の市場力学
  • 促進要因と機会
    • ハラール認証商品の需要の増加
    • イスラム教徒の意識の高まり
  • 抑制要因と課題
    • 規制上の課題
• PESTEL分析
• ハラール医薬品市場の用途動向
• バリューチェーン分析
• COVID-19の影響の分析

第5章 世界のハラール医薬品市場：医薬品別

• 主な調査結果
• イントロダクション
• OTC医薬品
• 化粧品
• 処方薬
• 栄養補助食品
• 医療機器

第6章 世界のハラール医薬品市場：剤形別

• 主な調査結果
• イントロダクション
• 注射剤
• 錠剤・カプセル
• 経口剤
• 外用剤
• その他

第7章 世界のハラール医薬品市場：治療領域別

• 主な調査結果
• イントロダクション
• 糖尿病
• 心血管疾患
• 消化器疾患
• 抗感染
• 呼吸器疾患
• 神経疾患
• 腫瘍
• その他

第8章 世界のハラール医薬品市場：認証タイプ別

• 主な調査結果
• イントロダクション
• ハラール国際標準
• ガルフ標準
• マレーシア標準
• その他

第9章 世界のハラール医薬品市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 薬局
• 病院・診療所
• オンライン薬局
• 小売業者
• その他

第10章 世界のハラール医薬品市場：地域

• 主な調査結果
• イントロダクション
  • ハラール医薬品市場の評価：地域（2020年～2034年）
• 北米
  • 北米：医薬品別（2020年～2034年）
  • 北米：剤形別（2020年～2034年）
  • 北米：治療領域別（2020年～2034年）
  • 北米：認証タイプ別（2020年～2034年）
  • 北米：エンドユーザー別（2020年～2034年）
  • 米国
  • カナダ
• 欧州
  • 欧州：医薬品別（2020年～2034年）
  • 欧州：剤形別（2020年～2034年）
  • 欧州：治療領域別（2020年～2034年）
  • 欧州：認証タイプ別（2020年～2034年）
  • 欧州：エンドユーザー別（2020年～2034年）
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他の欧州
• アジア太平洋
  • アジア太平洋：医薬品別（2020年～2034年）
  • アジア太平洋：剤形別（2020年～2034年）
  • アジア太平洋：治療領域別（2020年～2034年）
  • アジア太平洋：認証タイプ別（2020年～2034年）
  • アジア太平洋：エンドユーザー別（2020年～2034年）
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他のアジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：医薬品別（2020年～2034年）
  • 中東・アフリカ：剤形別（2020年～2034年）
  • 中東・アフリカ：治療領域別（2020年～2034年）
  • 中東・アフリカ：認証タイプ別（2020年～2034年）
  • 中東・アフリカ：エンドユーザー別（2020年～2034年）
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他の中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：医薬品別（2020年～2034年）
  • ラテンアメリカ：剤形別（2020年～2034年）
  • ラテンアメリカ：治療領域別（2020年～2034年）
  • ラテンアメリカ：認証タイプ別（2020年～2034年）
  • ラテンアメリカ：エンドユーザー別（2020年～2034年）
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他のラテンアメリカ

第11章 競合情勢

• 拡張と買収の分析
  • 拡大
  • 買収
• パートナーシップ/提携/合意/公開

第12章 企業プロファイル

• Alkem Laboratories Limited
• Amgen Inc.
• Bosch Pharmaceuticals
• Chemical Company of Malaysia Berhad
• EMBIL Pharmaceutical Co.
• Noor Vitamins
• Nutramedica Incorporated
• Pharmaniaga Bhd
• Rosemont Pharmaceuticals
• Simpor Pharma Sdn Bhd

List of Tables:

• Table 1 Global Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 2 Global Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 3 Global Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 4 Global Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 5 Global Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 6 North America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 7 North America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 8 North America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 9 North America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 10 North America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 11 US: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 12 US: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 13 US: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 14 US: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 15 US: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 16 Canada: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 17 Canada: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 18 Canada: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 19 Canada: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 20 Canada: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 21 Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 22 Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 23 Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 24 Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 25 Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 26 UK: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 27 UK: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 28 UK: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 29 UK: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 30 UK: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 31 France: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 32 France: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 33 France: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 34 France: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 35 France: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 36 Germany: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 37 Germany: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 38 Germany: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 39 Germany: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 40 Germany: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 41 Italy: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 42 Italy: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 43 Italy: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 44 Italy: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 45 Italy: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 46 Spain: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 47 Spain: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 48 Spain: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 49 Spain: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 50 Spain: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 51 Netherlands: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 52 Netherlands: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 53 Netherlands: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 54 Netherlands: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 55 Netherlands: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 56 Russia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 57 Russia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 58 Russia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 59 Russia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 60 Russia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 61 Rest of Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 62 Rest of Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 63 Rest of Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 64 Rest of Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 65 Rest of Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 66 Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 67 Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 68 Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 69 Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 70 Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 71 China: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 72 China: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 73 China: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 74 China: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 75 China: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 76 India: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 77 India: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 78 India: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 79 India: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 80 India: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 81 Malaysia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 82 Malaysia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 83 Malaysia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 84 Malaysia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 85 Malaysia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 86 Japan: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 87 Japan: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 88 Japan: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 89 Japan: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 90 Japan: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 91 Indonesia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 92 Indonesia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 93 Indonesia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 94 Indonesia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 95 Indonesia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 96 South Korea: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 97 South Korea: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 98 South Korea: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 99 South Korea: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 100 South Korea: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 101 Australia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 102 Australia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 103 Australia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 104 Australia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 105 Australia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 106 Rest of Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 107 Rest of Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 108 Rest of Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 109 Rest of Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 110 Rest of Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 111 Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 112 Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 113 Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 114 Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 115 Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 116 Saudi Arabia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 117 Saudi Arabia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 118 Saudi Arabia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 119 Saudi Arabia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 120 Saudi Arabia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 121 UAE: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 122 UAE: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 123 UAE: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 124 UAE: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 125 UAE: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 126 Israel: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 127 Israel: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 128 Israel: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 129 Israel: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 130 Israel: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 131 South Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 132 South Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 133 South Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 134 South Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 135 South Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 136 Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 137 Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 138 Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 139 Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 140 Rest of Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 141 Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 142 Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 143 Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 144 Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 145 Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 146 Mexico: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 147 Mexico: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 148 Mexico: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 149 Mexico: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 150 Mexico: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 151 Brazil: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 152 Brazil: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 153 Brazil: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 154 Brazil: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 155 Brazil: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 156 Argentina: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 157 Argentina: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 158 Argentina: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 159 Argentina: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 160 Argentina: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• Table 161 Rest of Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• Table 162 Rest of Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• Table 163 Rest of Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• Table 164 Rest of Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• Table 165 Rest of Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)

List of Figures:

• Figure 1. Global Halal Pharmaceuticals Market, 2020-2034 (USD Billion)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Drug
• Figure 7. Global Halal Pharmaceuticals Market, by Drug, 2024 & 2034 (USD Billion)
• Figure 8. Market by Dosage Form
• Figure 9. Global Halal Pharmaceuticals Market, by Dosage Form, 2024 & 2034 (USD Billion)
• Figure 10. Market by Therapeutic Area
• Figure 11. Global Halal Pharmaceuticals Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
• Figure 12. Market by Certification Type
• Figure 13. Global Halal Pharmaceuticals Market, by Certification Type, 2024 & 2034 (USD Billion)
• Figure 14. Market by End Users
• Figure 15. Global Halal Pharmaceuticals Market, by End Users, 2024 & 2034 (USD Billion)

The global halal pharmaceuticals market size is expected to reach USD 205.30 billion by 2034, according to a new study by Polaris Market Research. The report "Halal Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Drug, Dosage Form (Injectables, Tablets & Capsules, Orals, Topicals, and Others), Therapeutic Area, Certification Type, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Halal pharmaceuticals are medications that comply with Islamic law and do not contain any haram (prohibited) components. While there are some similarities between conventional pharmaceutical production and the halal certification process, key differences exist. Halal pharmaceutical ingredients are derived from plants, minerals, water, and animals slaughtered in accordance with Islamic law. Marine creatures are considered halal, and synthetic materials are permitted as long as they are free from impurities (najis) and safe for human consumption.

Government policies, such as taxes, subsidies, and restrictions, significantly influence market growth. In many Muslim-majority countries, regulations mandating halal certifications for pharmaceuticals help drive market demand for compliant products. In addition, subsidies for halal pharmaceutical research and production encourage innovation and investment. Regulatory frameworks promoting halal standards further create a favorable environment for the halal pharmaceuticals market expansion.

The growing demand for organic and environmentally friendly products is one of the major market trends anticipated to drive market development in the coming years. The improving economic climate in Islamic nations is projected to provide several halal pharmaceuticals market opportunities during the forecast period.

Key Highlights of Halal Pharmaceuticals Market

Based on drugs, the prescription drugs segment accounted for the largest market share in 2024, driven by the growing prevalence of chronic illnesses and the rising need for drugs with halal certification.

Based on dosage form, the tablets & capsules segment led the market with a 50% revenue share in 2024. This is primarily attributed to the convenience, patient compliance, and accessibility of tablet and capsule administration among patients.

North America accounted for a significant portion of the global halal medicines market in 2024 due to the region's growing Muslim population and rising consumer awareness of ingredients and sourcing.

The Asia Pacific halal pharmaceuticals market is projected to witness the fastest growth during the forecast period, driven by the significant Muslim population in the region.

Rosemont Pharmaceuticals, EMBIL Pharmaceutical Co., Noor Vitamins, Bosch Pharmaceuticals, Chemical Company of Malaysia Berhad, Pharmaniaga Bhd, Nutramedica Incorporated, and Simpor Pharma Sdn Bhd are a few of the key players in the market.

Polaris Market Research has segmented the global halal pharmaceuticals market report on the basis of drug, dosage form, therapeutic area, certification type, end users, and region:

Halal Pharmaceuticals Market Segmentation

By Drug Outlook (Revenue - USD Billion, 2020-2034)

• Over-The-Counter (OTC) drugs
• Cosmetics
• Prescription Drugs
• Nutraceuticals
• Medical Devices

By Dosage Form Outlook (Revenue - USD Billion, 2020-2034)

• Injectables
• Tablets & Capsules
• Orals
• Topicals
• Others

By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)

• Diabetes
• Cardiovascular Diseases
• Gastrointestinal Disorders
• Anti-Infectives
• Respiratory Diseases
• Neurological Disorders
• Oncology
• Others

By Certification Type Outlook (Revenue - USD Billion, 2020-2034)

• Halal International Standard
• Gulf Standard
• Malaysia Standard
• Others

By End Users Outlook (Revenue - USD Billion, 2020-2034)

• Pharmacies
• Hospitals & Clinics
• Online Pharmacies
• Retailers
• Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

• North America
• US
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Mexico
• Brazil
• Argentina
• Rest of Latin America

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Halal Pharmaceuticals Market Insights

• 4.1. Halal Pharmaceuticals Market - Application Snapshot
• 4.2. Halal Pharmaceuticals Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Growing Demand for Halal-Certified Goods
    • 4.2.1.2. Increasing Awareness Among Muslim Population
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Regulatory Challenges
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry Among Existing Firms (High)
• 4.4. PESTEL Analysis
• 4.5. Halal Pharmaceuticals Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Halal Pharmaceuticals Market, by Drug

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
• 5.3. Over-The-Counter (OTC) Drugs
  • 5.3.1. Global Halal Pharmaceuticals Market, by Over-The-Counter (OTC) Drugs, by Region, 2020-2034 (USD Billion)
• 5.4. Cosmetics
  • 5.4.1. Global Halal Pharmaceuticals Market, by Cosmetics, by Region, 2020-2034 (USD Billion)
• 5.5. Prescription Drugs
  • 5.5.1. Global Halal Pharmaceuticals Market, by Prescription Drugs, by Region, 2020-2034 (USD Billion)
• 5.6. Nutraceuticals
  • 5.6.1. Global Halal Pharmaceuticals Market, by Nutraceuticals, by Region, 2020-2034 (USD Billion)
• 5.7. Medical Devices
  • 5.7.1. Global Halal Pharmaceuticals Market, by Medical Devices, by Region, 2020-2034 (USD Billion)

6. Global Halal Pharmaceuticals Market, by Dosage Form

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
• 6.3. Injectables
  • 6.3.1. Global Halal Pharmaceuticals Market, by Injectables, by Region, 2020-2034 (USD Billion)
• 6.4. Tablets & Capsules
  • 6.4.1. Global Halal Pharmaceuticals Market, by Tablets & Capsules, by Region, 2020-2034 (USD Billion)
• 6.5. Orals
  • 6.5.1. Global Halal Pharmaceuticals Market, by Orals, by Region, 2020-2034 (USD Billion)
• 6.6. Topicals
  • 6.6.1. Global Halal Pharmaceuticals Market, by Topicals, by Region, 2020-2034 (USD Billion)
• 6.7. Others
  • 6.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Halal Pharmaceuticals Market, by Therapeutic Area

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
• 7.3. Diabetes
  • 7.3.1. Global Halal Pharmaceuticals Market, by Diabetes, by Region, 2020-2034 (USD Billion)
• 7.4. Cardiovascular Diseases
  • 7.4.1. Global Halal Pharmaceuticals Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
• 7.5. Gastrointestinal Diseases
  • 7.5.1. Global Halal Pharmaceuticals Market, by Gastrointestinal Diseases, by Region, 2020-2034 (USD Billion)
• 7.6. Anti-infectives
  • 7.6.1. Global Halal Pharmaceuticals Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
• 7.7. Respiratory Diseases
  • 7.7.1. Global Halal Pharmaceuticals Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
• 7.8. Neurological Diseases
  • 7.8.1. Global Halal Pharmaceuticals Market, by Neurological Diseases, by Region, 2020-2034 (USD Billion)
• 7.9. Oncology
  • 7.9.1. Global Halal Pharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
• 7.10. Others
  • 7.10.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Halal Pharmaceuticals Market, by Certification Type

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
• 8.3. Halal International Standard
  • 8.3.1. Global Halal Pharmaceuticals Market, by Halal International Standard, by Region, 2020-2034 (USD Billion)
• 8.4. Gulf Standard
  • 8.4.1. Global Halal Pharmaceuticals Market, by Gulf Standard, by Region, 2020-2034 (USD Billion)
• 8.5. Malaysia Standard
  • 8.5.1. Global Halal Pharmaceuticals Market, by Malaysia Standard, by Region, 2020-2034 (USD Billion)
• 8.6. Others
  • 8.6.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Halal Pharmaceuticals Market, by End Users

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Global Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• 9.3. Pharmacies
  • 9.3.1. Global Halal Pharmaceuticals Market, by Pharmacies, by Region, 2020-2034 (USD Billion)
• 9.4. Hospitals & Clinics
  • 9.4.1. Global Halal Pharmaceuticals Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
• 9.5. Online Pharmacies
  • 9.5.1. Global Halal Pharmaceuticals Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)
• 9.6. Retailers
  • 9.6.1. Global Halal Pharmaceuticals Market, by Retailers, by Region, 2020-2034 (USD Billion)
• 9.7. Others
  • 9.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

10. Global Halal Pharmaceuticals Market, by Geography

• 10.1. Key Findings
• 10.2. Introduction
  • 10.2.1. Halal Pharmaceuticals Market Assessment, by Geography, 2020-2034 (USD Billion)
• 10.3. Halal Pharmaceuticals Market - North America
  • 10.3.1. North America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  • 10.3.2. North America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  • 10.3.3. North America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 10.3.4. North America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  • 10.3.5. North America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.3.6. Halal Pharmaceuticals Market - US
    • 10.3.6.1. US: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.3.6.2. US: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.3.6.3. US: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.3.6.4. US: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.3.6.5. US: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.3.7. Halal Pharmaceuticals Market - Canada
    • 10.3.7.1. Canada: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.3.7.2. Canada: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.3.7.3. Canada: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.3.7.4. Canada: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.3.7.5. Canada: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• 10.4. Halal Pharmaceuticals Market - Europe
  • 10.4.1. Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  • 10.4.2. Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  • 10.4.3. Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 10.4.4. Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  • 10.4.5. Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.6. Halal Pharmaceuticals Market - UK
    • 10.4.6.1. UK: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.6.2. UK: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.6.3. UK: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.6.4. UK: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.6.5. UK: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.7. Halal Pharmaceuticals Market - France
    • 10.4.7.1. France: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.7.2. France: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.7.3. France: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.7.4. France: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.7.5. France: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.8. Halal Pharmaceuticals Market - Germany
    • 10.4.8.1. Germany: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.8.2. Germany: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.8.3. Germany: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.8.4. Germany: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.8.5. Germany: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.9. Halal Pharmaceuticals Market - Italy
    • 10.4.9.1. Italy: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.9.2. Italy: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.9.3. Italy: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.9.4. Italy: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.9.5. Italy: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.10. Halal Pharmaceuticals Market - Spain
    • 10.4.10.1. Spain: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.10.2. Spain: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.10.3. Spain: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.10.4. Spain: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.10.5. Spain: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.11. Halal Pharmaceuticals Market - Netherlands
    • 10.4.11.1. Netherlands: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.11.2. Netherlands: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.11.3. Netherlands: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.11.4. Netherlands: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.11.5. Netherlands: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.12. Halal Pharmaceuticals Market - Russia
    • 10.4.12.1. Russia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.12.2. Russia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.12.3. Russia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.12.4. Russia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.12.5. Russia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.4.13. Halal Pharmaceuticals Market - Rest of Europe
    • 10.4.13.1. Rest of Europe: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.4.13.2. Rest of Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.4.13.3. Rest of Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.4.13.4. Rest of Europe: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.4.13.5. Rest of Europe: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• 10.5. Halal Pharmaceuticals Market - Asia Pacific
  • 10.5.1. Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  • 10.5.2. Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  • 10.5.3. Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 10.5.4. Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  • 10.5.5. Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.6. Halal Pharmaceuticals Market - China
    • 10.5.6.1. China: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.6.2. China: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.6.3. China: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.6.4. China: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.6.5. China: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.7. Halal Pharmaceuticals Market - India
    • 10.5.7.1. India: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.7.2. India: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.7.3. India: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.7.4. India: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.7.5. India: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.8. Halal Pharmaceuticals Market - Malaysia
    • 10.5.8.1. Malaysia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.8.2. Malaysia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.8.3. Malaysia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.8.4. Malaysia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.8.5. Malaysia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.9. Halal Pharmaceuticals Market - Japan
    • 10.5.9.1. Japan: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.9.2. Japan: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.9.3. Japan: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.9.4. Japan: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.9.5. Japan: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.10. Halal Pharmaceuticals Market - Indonesia
    • 10.5.10.1. Indonesia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.10.2. Indonesia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.10.3. Indonesia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.10.4. Indonesia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.10.5. Indonesia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.11. Halal Pharmaceuticals Market - South Korea
    • 10.5.11.1. South Korea: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.11.2. South Korea: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.11.3. South Korea: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.11.4. South Korea: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.11.5. South Korea: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.12. Halal Pharmaceuticals Market - Australia
    • 10.5.12.1. Australia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.12.2. Australia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.12.3. Australia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.12.4. Australia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.12.5. Australia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.5.13. Halal Pharmaceuticals Market - Rest of Asia Pacific
    • 10.5.13.1. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.5.13.2. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.5.13.3. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.5.13.4. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.5.13.5. Rest of Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• 10.6. Halal Pharmaceuticals Market - Middle East & Africa
  • 10.6.1. Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  • 10.6.2. Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  • 10.6.3. Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 10.6.4. Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  • 10.6.5. Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.6.6. Halal Pharmaceuticals Market - Saudi Arabia
    • 10.6.6.1. Saudi Arabia: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.6.6.2. Saudi Arabia: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.6.6.3. Saudi Arabia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.6.6.4. Saudi Arabia: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.6.6.5. Saudi Arabia: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.6.7. Halal Pharmaceuticals Market - UAE
    • 10.6.7.1. UAE: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.6.7.2. UAE: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.6.7.3. UAE: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.6.7.4. UAE: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.6.7.5. UAE: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.6.8. Halal Pharmaceuticals Market - Israel
    • 10.6.8.1. Israel: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.6.8.2. Israel: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.6.8.3. Israel: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.6.8.4. Israel: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.6.8.5. Israel: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.6.9. Halal Pharmaceuticals Market - South Africa
    • 10.6.9.1. South Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.6.9.2. South Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.6.9.3. South Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.6.9.4. South Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.6.9.5. South Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.6.10. Halal Pharmaceuticals Market - Rest of Middle East & Africa
    • 10.6.10.1. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.6.10.2. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.6.10.3. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.6.10.4. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.6.10.5. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
• 10.7. Halal Pharmaceuticals Market - Latin America
  • 10.7.1. Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
  • 10.7.2. Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
  • 10.7.3. Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
  • 10.7.4. Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
  • 10.7.5. Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.7.6. Halal Pharmaceuticals Market - Mexico
    • 10.7.6.1. Mexico: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.7.6.2. Mexico: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.7.6.3. Mexico: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.7.6.4. Mexico: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.7.6.5. Mexico: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.7.7. Halal Pharmaceuticals Market - Brazil
    • 10.7.7.1. Brazil: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.7.7.2. Brazil: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.7.7.3. Brazil: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.7.7.4. Brazil: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.7.7.5. Brazil: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.7.8. Halal Pharmaceuticals Market - Argentina
    • 10.7.8.1. Argentina: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.7.8.2. Argentina: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.7.8.3. Argentina: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.7.8.4. Argentina: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.7.8.5. Argentina: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)
  • 10.7.9. Halal Pharmaceuticals Market - Rest of Latin America
    • 10.7.9.1. Rest of Latin America: Halal Pharmaceuticals Market, by Drug, 2020-2034 (USD Billion)
    • 10.7.9.2. Rest of Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020-2034 (USD Billion)
    • 10.7.9.3. Rest of Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020-2034 (USD Billion)
    • 10.7.9.4. Rest of Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020-2034 (USD Billion)
    • 10.7.9.5. Rest of Latin America: Halal Pharmaceuticals Market, by End Users, 2020-2034 (USD Billion)

11. Competitive Landscape

• 11.1. Expansion and Acquisition Analysis
  • 11.1.1. Expansion
  • 11.1.2. Acquisitions
• 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

• 12.1. Alkem Laboratories Limited
  • 12.1.1. Company Overview
  • 12.1.2. Financial Performance
  • 12.1.3. Product Benchmarking
  • 12.1.4. Recent Development
• 12.2. Amgen Inc.
  • 12.2.1. Company Overview
  • 12.2.2. Financial Performance
  • 12.2.3. Product Benchmarking
  • 12.2.4. Recent Development
• 12.3. Bosch Pharmaceuticals
  • 12.3.1. Company Overview
  • 12.3.2. Financial Performance
  • 12.3.3. Product Benchmarking
  • 12.3.4. Recent Development
• 12.4. Chemical Company of Malaysia Berhad
  • 12.4.1. Company Overview
  • 12.4.2. Financial Performance
  • 12.4.3. Product Benchmarking
  • 12.4.4. Recent Development
• 12.5. EMBIL Pharmaceutical Co.
  • 12.5.1. Company Overview
  • 12.5.2. Financial Performance
  • 12.5.3. Product Benchmarking
  • 12.5.4. Recent Development
• 12.6. Noor Vitamins
  • 12.6.1. Company Overview
  • 12.6.2. Financial Performance
  • 12.6.3. Product Benchmarking
  • 12.6.4. Recent Development
• 12.7. Nutramedica Incorporated
  • 12.7.1. Company Overview
  • 12.7.2. Financial Performance
  • 12.7.3. Product Benchmarking
  • 12.7.4. Recent Development
• 12.8. Pharmaniaga Bhd
  • 12.8.1. Company Overview
  • 12.8.2. Financial Performance
  • 12.8.3. Product Benchmarking
  • 12.8.4. Recent Development
• 12.9. Rosemont Pharmaceuticals
  • 12.9.1. Company Overview
  • 12.9.2. Financial Performance
  • 12.9.3. Product Benchmarking
  • 12.9.4. Recent Development
• 12.10. Simpor Pharma Sdn Bhd
  • 12.10.1. Company Overview
  • 12.10.2. Financial Performance
  • 12.10.3. Product Benchmarking
  • 12.10.4. Recent Development